Rare diseases
Investigational molecules
Locations
Testing dapagliflozin to slow kidney function decline in patients with autosomal dominant polycystic kidney disease
The NetherlandsA study to test the safety and effectiveness of BAY 3713372 alone and with drug combination in patients with MTAP-deleted solid tumors
The NetherlandsA study comparing erdafitinib delivery system to chemotherapy for patients with high-risk non-muscle-invasive bladder cancer who received BCG treatment
The NetherlandsVorasidenib for patients with IDH-mutant grade 2 or 3 astrocytoma after completing first-line chemoradiotherapy
The NetherlandsA Follow-up Study of Mezagitamab in Adults with Chronic Primary Immune Thrombocytopenia to Evaluate Long-term Safety and Effectiveness
The NetherlandsA Study of Tulisokibart for Adults with Radiographic Axial Spondyloarthritis (Ankylosing Spondylitis)
The NetherlandsStudy of Different Dosing Schedules of Osimertinib in Patients with EGFR Mutated Advanced or Metastatic Non-Small Cell Lung Cancer
The NetherlandsA Study of Mezagitamab Compared to Placebo for Adults with Chronic Primary Immune Thrombocytopenia
The NetherlandsA study comparing BNT323 with chemotherapy in patients with HER2-expressing recurrent endometrial cancer who received previous treatment
The NetherlandsStudy of methadone and morphine combination for pain relief in patients with bone metastases from cancer
The NetherlandsStudy of IMVT-1402 Treatment for Adults with Graves' Disease
The NetherlandsStudy of daratumumab, teclistamab and talquetamab combination treatment for frail patients with newly diagnosed multiple myeloma
The NetherlandsTell us about your condition – we search every trial in Europe and connect you with the right site.
